APA (7th ed.) Citation

Besson, J., Etcheverry, A., Nadaradjane, A., Bougras-Cartron, G., Aubry, M., Frenel, J., . . . Cartron, P. (2025). Selective disruption of DNMT1/ELK1 interactions induces DGKI re-expression and promotes temozolomide sensitivity of MGMTmethylated/DGKImethylated glioblastoma. Clinical Epigenetics, 17(1), 1. https://doi.org/10.1186/s13148-025-01943-8

Chicago Style (17th ed.) Citation

Besson, Jean-Maxime, et al. "Selective Disruption of DNMT1/ELK1 Interactions Induces DGKI Re-expression and Promotes Temozolomide Sensitivity of MGMTmethylated/DGKImethylated Glioblastoma." Clinical Epigenetics 17, no. 1 (2025): 1. https://doi.org/10.1186/s13148-025-01943-8.

MLA (9th ed.) Citation

Besson, Jean-Maxime, et al. "Selective Disruption of DNMT1/ELK1 Interactions Induces DGKI Re-expression and Promotes Temozolomide Sensitivity of MGMTmethylated/DGKImethylated Glioblastoma." Clinical Epigenetics, vol. 17, no. 1, 2025, p. 1, https://doi.org/10.1186/s13148-025-01943-8.